The growing popularity of weight loss drugs like Ozempic, Mounjaro, and Wegovy raises concerns about accessibility, sustainability, and holistic health approaches – but, what is driving this demand?
Novo Nordisk
Latest in Novo Nordisk
Alzheimer
Semaglutide can offset Alzheimer’s disease risk in diabetics by 40-70%
It’s the active ingredient in Novo Nordisk’s Ozempic and Wegovy; Study done in comparison of seven popular diabetes medicines
Novo Nordisk
WHO warns users to be careful of fake batches of Ozempic
Three falsified batches found in Brazil, the United Kingdom and the United States towards the end of last year
Novo Nordisk
Weight-loss drugmaker Novo Nordisk makes fresh push into heart drugs with $1.1bn Cardior Pharmaceuticals buy
The acquisition deal is seen as part of the Danish pharma major’s plans to expand big into the cardio-vascular segment
Diabetes
Obesity drug Wegovy shows promising results for heart health
Obesity breakthrough: Novo Nordisk’s Wegovy cuts heart attack risk by 20% in clinical trial
Abu Dhabi
UAE’s health sector witnesses two new international tie-ups
Emirates Health Services enters into an MoU with Novo Nordisk Pharma Gulf, while Moorfields Eye Hospital Abu Dhabi enters into a strategic arrangement with Imperial College London Diabetes Centre